Rani Y Upadhyay, MD
Interventional Cardiology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 13
Offices
13 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Upadhyay’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A119870 · Current
Licensed to practise in California · since 2012 · expires 2027-07-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$194,319
Medicare paid this office $194,319 for 906 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 187 | $30,550 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $28,457 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $23,647 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 237 | $14,014 | $57 |
| Critical care, first 30-74 minutes | 45 | $12,113 | $184 |
See all 28 services
| Return visit (30+ min) | 187 | $30,550 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $28,457 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $23,647 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 237 | $14,014 | $57 |
| Critical care, first 30-74 minutes | 45 | $12,113 | $184 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $11,238 | $388 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $11,129 | $199 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,019 | $153 |
| Long return visit (40+ min) | 43 | $8,342 | $167 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $5,282 | $240 |
| New patient visit (60+ min) | 25 | $4,594 | $184 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $3,260 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $2,694 | $13 |
| External shock to heart to regulate heart beat | 25 | $2,606 | $97 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,255 | $173 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $1,870 | $78 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,605 | $59 |
| New patient visit (45+ min) | 11 | $1,551 | $141 |
| Heart muscle strain imaging | 28 | $1,077 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $831 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $773 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $754 | $24 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $651 | $59 |
| Ultrasound of heart, follow-up | 16 | $371 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $329 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $288 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $220 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $68 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 25 | More than 57% of doctors who do this |
Who their Medicare patients are
906 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 18% · Women 49% · Also on Medicaid 39% · Health risk score 2.13. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Heart failure 48% · Chronic kidney disease 45% · Atrial fibrillation 41% · Diabetes 38% · Depression 23% · COPD 20% · Stroke 19% · Cancer 18% · Dementia 12%.
The office billed $873,962, Medicare allowed $252,418 and paid $194,319; for 1,978 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 906 | 1,978 | 76 | 2.13 | $873,962 | $194,319 |
| 2023 | 924 | 1,919 | 76 | 1.97 | $891,074 | $171,697 |
| 2022 | 1,131 | 2,265 | 76 | 1.80 | $1,074,848 | $203,078 |
| 2021 | 1,468 | 2,780 | 76 | 1.86 | $1,268,308 | $251,820 |
| 2020 | 1,074 | 2,012 | 75 | 2.18 | $1,096,282 | $198,158 |
| 2019 | 1,244 | 2,429 | 75 | 2.23 | $1,243,947 | $239,666 |
| 2018 | 415 | 766 | 75 | 2.16 | $416,842 | $83,907 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 164 | $28,021 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $22,109 | $123 |
| Return visit (30+ min) | 136 | $15,107 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 212 | $13,268 | $61 |
| Critical care, first 30-74 minutes | 41 | $11,849 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $10,762 | $154 |
| Long return visit (40+ min) | 67 | $10,214 | $146 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $8,669 | $433 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,490 | $541 |
| New patient visit (60+ min) | 29 | $4,942 | $170 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $4,514 | $205 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $4,382 | $175 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,921 | $243 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $2,665 | $133 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 25 | $2,040 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $1,236 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,223 | $94 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $980 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $944 | $24 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $794 | $57 |
| Programming of dual lead pacemaker system | 14 | $761 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $583 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $565 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 70 | $475 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $322 | $12 |
| Ultrasound of heart, follow-up | 13 | $309 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $189 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $189 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $183 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $78 | $5 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $69 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $58 | $3 |
2022: 35 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 282 | $40,446 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 176 | $26,424 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 310 | $19,337 | $60 |
| Return visit (30+ min) | 158 | $16,109 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $15,281 | $172 |
| Critical care, first 30-74 minutes | 42 | $14,999 | $187 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,777 | $431 |
| Long return visit (40+ min) | 73 | $10,061 | $126 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $3,989 | $160 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,734 | $249 |
| New patient visit (60+ min) | 22 | $3,580 | $163 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $2,845 | $178 |
| Hospital discharge day management, more than 30 minutes | 21 | $1,958 | $93 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $1,928 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,905 | $95 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,729 | $144 |
| New patient visit (45+ min) | 17 | $1,657 | $97 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,633 | $96 |
| External shock to heart to regulate heart beat | 14 | $1,368 | $98 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 21 | $1,313 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 82 | $1,118 | $13 |
| Heart muscle strain imaging | 28 | $1,090 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $546 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $502 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $437 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $433 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $425 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $403 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $308 | $6 |
| Ultrasound of heart, follow-up | 12 | $291 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $286 | $16 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 40 | $191 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 26 | $181 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $83 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $70 | $6 |
2021: 32 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 362 | $50,538 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 235 | $35,923 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 337 | $21,954 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $20,216 | $180 |
| Return visit (30+ min) | 166 | $17,820 | $84 |
| Critical care, first 30-74 minutes | 54 | $15,553 | $194 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $14,803 | $449 |
| Long return visit (40+ min) | 72 | $11,081 | $127 |
| New patient visit (60+ min) | 37 | $6,546 | $177 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $4,950 | $177 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $3,669 | $183 |
| New patient visit (45+ min) | 32 | $3,363 | $105 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,300 | $254 |
| Hospital discharge day management, more than 30 minutes | 31 | $2,995 | $97 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 36 | $2,946 | $82 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,372 | $132 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 35 | $2,195 | $63 |
| Heart muscle strain imaging | 42 | $1,716 | $41 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,662 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 216 | $1,442 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 80 | $1,186 | $13 |
| Programming of dual lead pacemaker system | 12 | $966 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 40 | $733 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $707 | $26 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $622 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 44 | $555 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $353 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $332 | $20 |
| Ultrasound of heart, follow-up | 11 | $251 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $233 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $197 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $51 | $3 |
2020: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 260 | $38,162 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 238 | $36,176 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $16,211 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,883 | $183 |
| Critical care, first 30-74 minutes | 45 | $14,606 | $200 |
| Return visit (30+ min) | 130 | $12,380 | $68 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $10,411 | $434 |
| New patient visit (45+ min) | 67 | $7,640 | $114 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $5,705 | $211 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $5,533 | $198 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,683 | $246 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $2,146 | $72 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,609 | $85 |
| Short return visit (20+ min) | 22 | $1,498 | $65 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,219 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $713 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $626 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 28 | $608 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $564 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $527 | $11 |
| Ultrasound of heart, follow-up | 17 | $453 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 59 | $396 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $291 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $207 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $139 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $47 | $3 |
2019: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 329 | $51,723 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 308 | $49,010 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 153 | $29,029 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 277 | $17,849 | $64 |
| New patient visit (45+ min) | 109 | $13,461 | $123 |
| Return visit (30+ min) | 101 | $11,329 | $86 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $10,775 | $399 |
| Critical care, first 30-74 minutes | 34 | $9,087 | $193 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $6,479 | $196 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,497 | $204 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $5,480 | $249 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $2,545 | $98 |
| Short return visit (20+ min) | 36 | $2,033 | $55 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,555 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 65 | $1,150 | $16 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $979 | $89 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $715 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $704 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 94 | $701 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 35 | $672 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $396 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 36 | $379 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $219 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $219 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $147 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $92 | $3 |
2018: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $21,836 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $18,343 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,264 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $4,878 | $64 |
| New patient visit (45+ min) | 28 | $4,203 | $150 |
| Critical care, first 30-74 minutes | 11 | $2,718 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,134 | $65 |
| Short return visit (20+ min) | 19 | $1,300 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | $780 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $142 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $133 | $10 |
Medicaid work
$6,902 in 2024
Medicaid paid $6,902 for 305 billed services this clinician did in 2024, up to 36 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 284 | $6,194 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $708 |
| 2024 | 305 | 2 | 36 | $6,902 |
| 2023 | 463 | 3 | 50 | $14,155 |
| 2022 | 521 | 2 | 79 | $15,518 |
| 2021 | 606 | 4 | 51 | $21,522 |
| 2020 | 408 | 2 | 37 | $11,509 |
| 2019 | 572 | 4 | 49 | $16,475 |
| 2018 | 215 | 2 | 33 | $6,569 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 277 | $8,164 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 173 | $5,980 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 13 | $11 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 411 | $11,626 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 110 | $3,893 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 401 | $11,690 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 179 | $8,694 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $975 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $163 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 293 | $7,693 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 115 | $3,816 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 372 | $11,273 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 176 | $4,868 |
| Return visit (30+ min) | 12 | $227 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $107 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 120 | $3,983 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 95 | $2,586 |
Drugs they prescribed that Part D paid
$198,403
Pharmacies billed $198,403 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,109) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
950 generic and 159 brand-name prescriptions · $198,403 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 75 | $82,109 | $1,095 |
| Xarelto | 47 | $68,721 | $1,462 |
| Rosuvastatin | 44 | $2,973 | $68 |
| Atorvastatin | 145 | $1,603 | $11 |
| Metoprolol | 90 | $1,224 | $14 |
See all 22 drugs
| Eliquis | 75 | $82,109 | $1,095 |
| Xarelto | 47 | $68,721 | $1,462 |
| Rosuvastatin | 44 | $2,973 | $68 |
| Atorvastatin | 145 | $1,603 | $11 |
| Metoprolol | 90 | $1,224 | $14 |
| Ezetimibe | 22 | $1,112 | $51 |
| Carvedilol | 82 | $1,108 | $14 |
| Flecainide Acetate | 16 | $1,087 | $68 |
| Potassium Chloride | 16 | $705 | $44 |
| Clopidogrel | 34 | $545 | $16 |
| Amlodipine Besylate | 60 | $544 | $9 |
| Diltiazem 24hr Er (Cd) | 20 | $506 | $25 |
| Nitroglycerin | 22 | $452 | $21 |
| Hydralazine | 33 | $442 | $13 |
| Metoprolol | 73 | $428 | $6 |
| Lisinopril | 48 | $416 | $9 |
| Losartan | 43 | $393 | $9 |
| Isosorbide Mononitrate Er | 19 | $261 | $14 |
| Chlorthalidone | 15 | $254 | $17 |
| Spironolactone | 37 | $201 | $5 |
| Furosemide | 25 | $182 | $7 |
| Hydrochlorothiazide | 15 | $121 | $8 |
Year by year
| 2024 | 1,109 | 233 | 0% (0) | 14% | $198,403 |
| 2023 | 798 | 183 | 0% (0) | 13% | $156,824 |
| 2022 | 1,092 | 193 | 0% (0) | 19% | $243,349 |
| 2021 | 1,004 | 193 | 0% (0) | 19% | $189,198 |
| 2020 | 612 | 121 | None | 18% | $88,424 |
| 2019 | 367 | 92 | None | 22% | $58,855 |
| 2018 | 121 | 48 | 0% (0) | 17% | $8,137 |
| 2017 | 85 | 20 | 0% (0) | 15% | $2,623 |
| 2016 | 126 | 22 | 0% (0) | None | $1,263 |
| 2015 | 68 | None | 0% (0) | 16% | $485 |
| 2014 | 113 | 20 | None | 18% | $2,761 |
| 2013 | 138 | 23 | None | None | $4,008 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Xarelto | 42 | $67,870 | $1,616 |
| Eliquis | 40 | $54,405 | $1,360 |
| Atorvastatin | 88 | $1,886 | $21 |
| Carvedilol | 66 | $1,508 | $23 |
| Rosuvastatin | 34 | $1,299 | $38 |
| Metoprolol | 62 | $1,141 | $18 |
| Flecainide Acetate | 15 | $1,080 | $72 |
| Diltiazem 24hr Er (Cd) | 20 | $795 | $40 |
| Potassium Chloride | 15 | $780 | $52 |
| Ezetimibe | 18 | $730 | $41 |
| Amlodipine Besylate | 56 | $588 | $10 |
| Losartan | 27 | $521 | $19 |
| Lisinopril | 34 | $467 | $14 |
| Chlorthalidone | 12 | $466 | $39 |
| Clopidogrel | 18 | $381 | $21 |
| Isosorbide Mononitrate Er | 17 | $356 | $21 |
| Spironolactone | 28 | $270 | $10 |
| Metoprolol | 36 | $255 | $7 |
| Nitroglycerin | 16 | $248 | $15 |
| Furosemide | 29 | $242 | $8 |
| Hydralazine | 17 | $224 | $13 |
| Hydrochlorothiazide | 15 | $84 | $6 |
2022: 26 drugs
| Xarelto | 78 | $98,620 | $1,264 |
| Eliquis | 64 | $86,297 | $1,348 |
| Entresto | 12 | $12,044 | $1,004 |
| Brilinta | 15 | $8,956 | $597 |
| Repatha Sureclick | 14 | $8,406 | $600 |
| Rosuvastatin | 39 | $2,574 | $66 |
| Atorvastatin | 110 | $1,857 | $17 |
| Metoprolol | 91 | $1,847 | $20 |
| Carvedilol | 100 | $1,687 | $17 |
| Flecainide Acetate | 15 | $1,653 | $110 |
| Potassium Chloride | 16 | $1,279 | $80 |
| Diltiazem 24hr Er (Cd) | 32 | $1,260 | $39 |
| Clopidogrel | 40 | $931 | $23 |
| Losartan | 33 | $647 | $20 |
| Ezetimibe | 15 | $583 | $39 |
| Lisinopril | 56 | $498 | $9 |
| Amlodipine Besylate | 60 | $479 | $8 |
| Chlorthalidone | 16 | $456 | $29 |
| Nitroglycerin | 12 | $418 | $35 |
| Spironolactone | 40 | $407 | $10 |
| Furosemide | 26 | $335 | $13 |
| Isosorbide Mononitrate Er | 27 | $333 | $12 |
| Hydralazine | 12 | $234 | $20 |
| Metoprolol | 44 | $201 | $5 |
| Simvastatin | 14 | $74 | $5 |
| Hydrochlorothiazide | 16 | $48 | $3 |
2021: 25 drugs
| Xarelto | 87 | $94,180 | $1,083 |
| Eliquis | 49 | $54,336 | $1,109 |
| Metoprolol | 105 | $2,212 | $21 |
| Rosuvastatin | 38 | $1,913 | $50 |
| Atorvastatin | 106 | $1,717 | $16 |
| Flecainide Acetate | 13 | $1,193 | $92 |
| Carvedilol | 77 | $1,138 | $15 |
| Clopidogrel | 42 | $807 | $19 |
| Potassium Chloride | 15 | $789 | $53 |
| Ezetimibe | 11 | $756 | $69 |
| Isosorbide Mononitrate Er | 24 | $674 | $28 |
| Diltiazem 24hr Er (Cd) | 22 | $626 | $28 |
| Chlorthalidone | 20 | $491 | $25 |
| Losartan | 30 | $487 | $16 |
| Lisinopril | 42 | $475 | $11 |
| Bumetanide | 13 | $468 | $36 |
| Nitroglycerin | 13 | $419 | $32 |
| Amlodipine Besylate | 49 | $412 | $8 |
| Metoprolol | 41 | $269 | $7 |
| Digoxin | 11 | $256 | $23 |
| Furosemide | 26 | $238 | $9 |
| Hydralazine | 11 | $226 | $21 |
| Spironolactone | 19 | $119 | $6 |
| Hydrochlorothiazide | 33 | $101 | $3 |
| Simvastatin | 13 | $87 | $7 |
2020: 15 drugs
| Xarelto | 68 | $60,908 | $896 |
| Metoprolol | 47 | $1,288 | $27 |
| Diltiazem 24hr Er (Cd) | 26 | $1,173 | $45 |
| Atorvastatin | 63 | $749 | $12 |
| Rosuvastatin | 18 | $592 | $33 |
| Clopidogrel | 23 | $466 | $20 |
| Carvedilol | 49 | $451 | $9 |
| Chlorthalidone | 20 | $449 | $22 |
| Lisinopril | 36 | $324 | $9 |
| Losartan | 19 | $275 | $14 |
| Metoprolol | 40 | $254 | $6 |
| Furosemide | 20 | $162 | $8 |
| Amlodipine Besylate | 18 | $96 | $5 |
| Simvastatin | 14 | $93 | $7 |
| Hydrochlorothiazide | 25 | $76 | $3 |
2019: 12 drugs
| Xarelto | 60 | $48,398 | $807 |
| Metoprolol | 21 | $792 | $38 |
| Chlorthalidone | 17 | $673 | $40 |
| Diltiazem 24hr Er (Cd) | 18 | $540 | $30 |
| Atorvastatin | 20 | $393 | $20 |
| Clopidogrel | 20 | $302 | $15 |
| Carvedilol | 28 | $296 | $11 |
| Amlodipine Besylate | 23 | $245 | $11 |
| Lisinopril | 20 | $140 | $7 |
| Losartan | 12 | $139 | $12 |
| Metoprolol | 33 | $126 | $4 |
| Hydrochlorothiazide | 25 | $107 | $4 |
2018: 1 drug
| Clopidogrel | 57 | $540 | $9 |
2017: 1 drug
| Clopidogrel | 11 | $200 | $18 |
2016: 5 drugs
| Allopurinol | 12 | $127 | $11 |
| Carvedilol | 26 | $118 | $5 |
| Simvastatin | 12 | $59 | $5 |
| Furosemide | 16 | $49 | $3 |
| Benazepril | 12 | $43 | $4 |
2015: 2 drugs
| Carvedilol | 15 | $90 | $6 |
| Benazepril | 11 | $58 | $5 |
2014: 1 drug
| Benazepril | 12 | $64 | $5 |
2013: 4 drugs
| Hydrochlorothiazide | 16 | $130 | $8 |
| Metformin | 13 | $121 | $9 |
| Amlodipine Besylate | 14 | $118 | $8 |
| Benazepril | 17 | $91 | $5 |
Money from drug and device companies
$158 in 2025
| 2025 | 2 | 3 | None | $158 |
| 2024 | 1 | 1 | None | $38 |
| 2023 | 2 | 3 | None | $199 |
| 2022 | 2 | 2 | None | $35 |
| 2021 | 5 | 8 | None | $120 |
| 2020 | 2 | 2 | None | $117 |
| 2019 | 2 | 4 | None | $55 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Therapies | $122 | 2 payments
|
| Abiomed | None | $36 | 1 payment
|
See all 3 published payments
| Abiomed | Meals · 2025-10-15 | None | $36 |
| Boston Scientific | Meals · 2025-07-31 | Lux-Dx Insertable Cardiac Monitor | $38 |
| Boston Scientific | Meals · 2025-02-22 | General - Therapies | $85 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $38
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $38 | 1 payment
|
2023: $199
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $179 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $20 | 1 payment
|
2022: $35
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $20 | 1 payment
|
| Chiesi USA | Kengreal | $15 | 1 payment
|
2021: $120
| Philips Electronics North America | (8333) Igt D Coronary | $37 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $29 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $24 | 2 payments
|
| Medtronic | Micra | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $11 | 1 payment
|
2020: $117
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $104 | 1 payment
|
| Medtronic Vascular | Resolute | $14 | 1 payment
|
2019: $55
| Medtronic Vascular | Resolute | $41 | 3 payments
|
| Abiomed | Impella | $14 | 1 payment
|
Professional record
- NPI
- 1770855009
- Licence
- CA A119870California A119870: Current · expires 2027-07-31
- Trained
- Wayne State University School of Medicine, 2010
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- Po Box 742244, Los Angeles, CA, 90074
- NPI first listed
- 2012-02-01
- NPI last updated
- 2024-10-17
- NPI record certified
- 2024-10-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2020 Zonal Ave, Los Angeles, CA, 90089